Elissa Wolfson[email protected]Genetic DisordersNGS working group provides recommendations for germline variant confirmationA joint report provides eight recommendations for standardizing orthogonal confirmation practices for germline variants detected by next-generation sequencing.May 19, 2023COVID-19Masking and air cleaners reduced COVID-19 in two Swiss schools: StudyFace masks and portable air cleaners effectively reduced the spread of SARS-CoV-2, the virus that causes COVID-19, in two Swiss schools.May 18, 2023Prostate CancerSome prostate cancer policies drive overdiagnosis, argue expertsProstate cancer test-by-request policies have led to excessive PSA testing for asymptomatic men, overdiagnosis, overtreatment, and inequity, contend experts.May 18, 2023Alzheimer'sAlzheimer’s disease and modifiable risk factors: Genetic associations revealedNovel genetic associations between increased Alzheimer’s disease risk and high HDL cholesterol and high systolic blood pressure were revealed in a study.May 17, 2023COVID-19Masking should continue in healthcare settings, some experts sayMasking in healthcare settings should continue in order to optimize patient safety, recommend infectious disease experts in a commentary.May 16, 2023HPVMailed HPV home test kits doubled cervical cancer screening rates in studyMailing human papillomavirus (HPV) self-collection kits for at-home use improved cervical cancer screening in under-screened, low-income women by nearly two-fold.May 12, 2023Clostridium DifficileResearchers find that prompt C. difficile testing could reduce hospital infection spread, morbidityHospital policies allowing nurses to independently initiate testing for the bacterium C. difficile could reduce infection spread and associated morbidity.May 11, 2023COVID-19A closer look at long COVID symptomsIntensively studied patients with persistent post-COVID neurological symptoms were found to have autonomic dysfunction and differences in their immune cell profiles.May 10, 2023Neurodegenerative DiseaseNanoparticles in study boost sensitivity of neurodegenerative disease testA technique under development promises faster, more accurate detection of human neurodegenerative diseases, including Alzheimer's and Parkinson's, and similar diseases in other animals.May 9, 2023Genetic DisordersCost-benefit analysis supports adoption of routine genetic testingA cost-benefit analysis recommends genetic testing of all adults under age 40 for three conditions posing a high risk of life-threatening illness.May 9, 2023Previous PagePage 4 of 15Next PageTop StoriesFDA Warning LetterFDA issues warning for Cue Health COVID-19 testsThe U.S. Food and Drug Administration (FDA) issued a warning to consumers and healthcare providers not to use Cue Health's COVID-19 over-the-counter test and its COVID-19 test intended for point-of-care settings due to an increased risk of false results.Emerging TechnologyBiomarker extraction through ultrasound shows promise for cancer detectionTrends and FinanceNorthwell Health Cancer Institute opens molecular diagnostics laboratoryConcussionDanaher launches collaboration with Johns Hopkins University on TBI diagnosticsSponsor ContentVisit our Molecular Diagnostics Community